COVID-19: Lagos To Use 600 Patients For Chloroquine Clinical Trials

The adaptation of Chloroquine for clinical trial as a potential drug in managing the symptoms of COVID-19 is based on data from other treatment centres across the world.

COVID-19: Lagos To Use 600 Patients For Chloroquine Clinical Trials
Chloroquine

Lagos State Commissioner for Information and Strategy, Mr. Gbenga Omotoso, on Saturday disclosed that the state had enlisted 600 patients for the planned chloroquine clinical trials.

The state discharged 45 more patients on Saturday.

The state’s Commissioner for Information, Gbenga Omotosho, made the disclosure.

Omotoso said an independent board, which would be inaugurated, would monitor the process and give necessary advice to the state government on the progress of the trial.

Omotoso said, “In summary, we will be looking at about 600 patients. The trial will go on till we recruit the required number.

"There will be an independent Data and Safety Board. The board can advise that study be discontinued if the statistical evidence of the usefulness of a drug is overwhelming and in which case it becomes unethical to withhold it from other groups.”

Also, Governor Babajide Sanwo-Olu has said the state was better able to handle COVID-19 given the experience it had with Ebola six years ago.

Sanwo-Olu said; “That was also epic in Lagos and it gave Lagos some understanding about how serious infectious disease could be managed.

 

READ ALSO:

COVID-19: Nigeria's Total Infections Hit 7,839 With 2,263 Recoveries

 

"We have an Infectious Disease Hospital in Yaba and even after the Ebola case, we had some international grants and over the last two to three years, we have built what we call a biosecurity lab level four, which can match any of its kind in the world."

The Lagos State Commissioner for Health, Akin Abayomi, had earlier in April said the state was going to hold clinical trials.

The adaptation of Chloroquine for clinical trial as a potential drug in managing the symptoms of COVID-19 is based on data from other treatment centers across the world. 

No state or federal government official has released data on treatment therapies used in their isolation/treatment centers.